Literature DB >> 2828757

Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases.

H Schweisfurth1, S Schiöberg-Schiegnitz, W Kuhn, B Parusel.   

Abstract

The angiotensin I converting enzyme activity (kininase II, EC 3.4.15.1) was measured fluorimetrically in cerebrospinal fluid (CACE) of 154 patients with neurological disorders and 27 controls. The concentrations of total protein, albumin, and immunoglobulins G and A were also determined. There was no correlation between CACE and sex or age, but a slight positive relation between CACE and total protein and an inverse correlation between CACE and albumin were observed. Compared to controls, significantly elevated CACE was found in acute untreated CNS sarcoidosis (P less than 0.0001), followed by viral encephalitis, CNS syphilis, Huntington's disease, and multiple sclerosis (P less than 0.001). In treated CNS sarcoidosis, only a minor increase of CACE was observed (P less than 0.05). The determination of CACE can be used for the diagnosis of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828757     DOI: 10.1007/BF01717829

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  Angiotensin-converting enzyme activity in isolated brain microvessels.

Authors:  M A Gimbrone; G R Majeau; W J Atkinson; W Sadler; S A Cruise
Journal:  Life Sci       Date:  1979-09-17       Impact factor: 5.037

2.  Fluorimetric determination of dipeptidyl carboxypeptidase. (angiotensin-I-converting enzyme).

Authors:  D Depierre; M Roth
Journal:  Enzyme       Date:  1975

3.  Angiotensin-converting enzyme: presence of high activity in choroid plexus of mammalian brain.

Authors:  A Arregui; L L Iversen
Journal:  Eur J Pharmacol       Date:  1978-11-01       Impact factor: 4.432

4.  CSF angiotensin-converting enzyme in neurosarcoidosis.

Authors:  V Oksanen; F Fyhrquist; C Grönhagen-Riska; H Somer
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

5.  Neurosarcoidosis.

Authors:  C P Chan Seem; E G Spokes
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

6.  Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas.

Authors:  E Silverstein; L P Pertschuk; J Friedland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Changes of serum angiotensin I converting enzyme in patients with viral hepatitis and liver cirrhosis.

Authors:  H Schweisfurth; H Wernze
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1979-06

8.  Increased urine angiotensin I converting enzyme activity in patients with upper urinary tract infection.

Authors:  B Baggio; S Favaro; S Cantaro; L Bertazzo; A Frunzio; A Borsatti
Journal:  Clin Chim Acta       Date:  1981-01-22       Impact factor: 3.786

9.  Assay and biochemical characterization of angiotensin-I-converting enzyme in cerebrospinal fluid.

Authors:  H Schweisfurth; S Schiöberg-Schiegnitz
Journal:  Enzyme       Date:  1984

10.  Properties of angiotensin-converting enzyme in intact cerebral microvessels.

Authors:  P Brecher; A Tercyak; A V Chobanian
Journal:  Hypertension       Date:  1981 Mar-Apr       Impact factor: 10.190

View more
  6 in total

1.  Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease.

Authors:  Arndt Manzel; Oliver Domenig; Bjoern Ambrosius; Agnes Kovacs; Johannes Stegbauer; Marko Poglitsch; Dominik N Mueller; Ralf Gold; Ralf A Linker
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-23       Impact factor: 4.147

2.  Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis: a meta-analysis.

Authors:  Smiljana Ristić; Nada Starčević Čizmarević; Juraj Sepčić; Miljenko Kapović; Borut Peterlin
Journal:  Neurol Sci       Date:  2016-08-27       Impact factor: 3.307

3.  The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis.

Authors:  Sergej Nadalin; Alena Buretić-Tomljanović; Polona Lavtar; Nada Starčević Čizmarević; Alenka Hodžić; Juraj Sepčić; Miljenko Kapović; Borut Peterlin; Smiljana Ristić
Journal:  Brain Behav       Date:  2016-11-14       Impact factor: 2.708

4.  Serum Level of the Angiotensin-Converting Enzyme in Patients with Idiopathic Acute Optic Neuritis: A Case-Control Study.

Authors:  Heshmatollah Ghanbari; Alireza Dehghani; Awat Feizi; Arman Amirkhani; Mohsen Pourazizi
Journal:  Scientifica (Cairo)       Date:  2020-03-26

Review 5.  The Renin-Angiotensin System in Huntington's Disease: Villain or Hero?

Authors:  Thatiane C G Machado; Cristina Guatimosim; Lucas M Kangussu
Journal:  Protein Pept Lett       Date:  2020       Impact factor: 1.890

6.  Renin-Angiotensin System in Huntington's Disease: Evidence from Animal Models and Human Patients.

Authors:  Lucas M Kangussu; Natalia P Rocha; Priscila A C Valadão; Thatiane C G Machado; Kívia B Soares; Julliane V Joviano-Santos; Leigh B Latham; Gabriela D Colpo; Ana Flávia Almeida-Santos; Erin Furr Stimming; Ana Cristina Simões E Silva; Antônio L Teixeira; Aline Silva Miranda; Cristina Guatimosim
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.